Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-05-02
1996-01-30
Chan, Nicky
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549436, 5483051, 548256, 544354, 514397, 514387, 514359, A61K 3136, C07D31768, C07D40512
Patent
active
054880645
ABSTRACT:
Compounds of the formula ##STR1## and pharmaceutically acceptable salts thereof where A is phenyl, naphthyl or dihydro- or tetrahydronaphthyl optionally substituted on the aromatic ring by one to three substituents independently selected from halogen, cyano, trifluoromethyl, nitro, alkoxy, alkylsulfonyl, alkyl, cycloalkyl, aryl or a hydrogen bond donor; B is a bond or an oxygen atom and R.sup.1 to R.sup.4 are as defined herein. These compounds are beta 3 adrenergic receptor agonists and are useful, therefore for example, in the treatment of diabetes, obesity and gastrointestinal diseases.
REFERENCES:
patent: 3432545 (1969-03-01), Howe
patent: 3501769 (1970-03-01), Crowther et al.
patent: 4338333 (1982-07-01), Ainsworth et al.
patent: 4772631 (1988-09-01), Holloway et al.
patent: 5061727 (1991-10-01), Bloom et al.
patent: 5064863 (1991-11-01), Alig et al.
Bristol--Myers Squibb Company
Chan Nicky
Park Ellen K.
LandOfFree
Benzo 1,3 dioxole derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzo 1,3 dioxole derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzo 1,3 dioxole derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-156794